Novozymes

Novozymes

Provides biological solutions to customers to achieve more efficient use of raw materials, reduce energy consumption, replace traditional chemicals with more sustainable alternatives.

Financials

Estimates*

Edit
Revenues, earnings & profits over time
DKK2020202120222023202420252026
Revenues14.0b15.0b17.6b17.9b29.4b31.3b33.5b
% growth(3 %)7 %17 %2 %64 %7 %7 %
EBITDA4.8b5.2b6.1b5.8b10.5b11.7b12.7b
% EBITDA margin34 %35 %35 %33 %36 %37 %38 %
Profit2.8b3.1b3.7b3.0b3.1b5.2b6.1b
% profit margin20 %21 %21 %17 %10 %17 %18 %
EV / revenue7.3x10.3x5.9x6.1x7.8x7.3x6.7x
EV / EBITDA21.2x29.6x17.0x18.7x21.9x19.6x17.8x
R&D budget1.9b2.0b2.0b2.0b---
R&D % of revenue14 %13 %11 %11 %---

Source: Dealroom estimates

  • Edit
DateInvestorsAmountRound
*

N/A

Corporate spinout
N/A

N/A

IPO
Total Funding-

Recent News about Novozymes

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Novozymes

Edit
Plant Response
ACQUISITION by The Mosaic Company Feb 2022
OrganoBalance GmbH
ACQUISITION by Novozymes Sep 2016
Chr. Hansen Holding A/S
ACQUISITION by Novozymes Dec 2022
TJ Technologies
ACQUISITION by Novozymes Jun 2013
Natural Industries
ACQUISITION by Novozymes Nov 2012
Delta Biotechnology
ACQUISITION by Novozymes Sep 2006
Synergia Life Sciences
ACQUISITION by Novozymes Nov 2021